Caisse De Depot Et Placement Du Quebec Legend Biotech Corp Transaction History

Caisse De Depot Et Placement Du Quebec

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	SELL	$43.42 - $57.37 $411,534 - $543,752	-9,478 Reduced 98.19%	175 $8,000
Q4 2022 Feb 14, 2023	SELL	$38.8 - $55.46 $318,160 - $454,772	-8,200 Reduced 45.93%	9,653 $481,000
Q3 2022 Nov 14, 2022	BUY	$38.15 - $57.1 $12,513 - $18,728	328 Added 1.87%	17,853 $728,000
Q2 2022 Aug 12, 2022	BUY	$33.54 - $55.0 $305,214 - $500,500	9,100 Added 108.01%	17,525 $964,000
Q1 2022 May 13, 2022	BUY	$31.02 - $48.18 $16,285 - $25,294	525 Added 6.65%	8,425 $306,000
Q4 2021 Feb 14, 2022	BUY	$41.14 - $56.98 $325,006 - $450,142	7,900 New	7,900 $368,000

225

74.3M

279K

350K

Ticker LEGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 167,403,008
Market Cap $5.49B
Description
Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...

Get notified when there are updates to the investment portfolio of Caisse De Depot Et Placement Du Quebec, based on Form 13F filings with the SEC.

Stay updated on Caisse De Depot Et Placement Du Quebec with notifications on news.